Post-Lyme borreliosis syndrome: A meta-analysis of reported symptoms

International Journal of Epidemiology

Volumn 34, Issue 6, 2005, Pages 1340-1345

  Cairns, Victoria ^a   Godwin, Jon ^b  

^a Consultant Statistician ^*  (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Borreliosis; Chronic Lyme; Lyme; Meta analysis; Post Lyme

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO;

HEALTH AND DISEASE;

ARTICLE; BONE PAIN; CHRONIC FATIGUE SYNDROME; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE DEFECT; DEPRESSION; FATIGUE; FIBROMYALGIA; HUMAN; LYME DISEASE; MEDLINE; META ANALYSIS; MYALGIA; PREVALENCE; PRIORITY JOURNAL; SYMPTOMATOLOGY; SYNDROME; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADULT; ARTHRALGIA; CHILD; CHRONIC DISEASE; COGNITION DISORDERS; FATIGUE; HUMANS; LYME DISEASE; MUSCULOSKELETAL DISEASES; SYNDROME;

EID: 29244480270     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyi129     Document Type: Article

References (33)

1. Steere AC. Lyme disease. New Engl J Med 2001;345:115-25.
2. Seltzer EG, Gerber MA, Cartter ML, Freudigman K, Shapiro ED. Longterm outcomes of persons with Lyme disease. JAMA 2000;283:609-16.
3. Shadick NA, Phillips CB, Logigian EL et al. The long-term clinical outcomes of Lyme disease. Ann Intern Med 1994;121:560-67.
4. Shadick NA, Phillips CB, Sangha O et al. Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann Intern Med 1999;131:919-26.
5. Vazquez M, Sparrow SS, Shapiro ED. Long-term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease. Pediatrics 2003;112:e93-97.
6. Wang TJ, Sangha O, Phillips CB et al. Outcomes of children treated for Lyme disease. J Rheumatol 1998;25:2249-53.
7. Kalish RA, Kaplan RF, Taylor E, Jones-Woodward L, Workman K, Steere AC. Evaluation of study patients with Lyme disease. 10-20-year follow-up. J Infect Dis 2001;183:453-60.
8. Benke T, Gasse T, Hittmair-Delazer M, Schmutzhard E. Lyme encephalopathy: Long-term neuropsychological deficits years after acute neuroborreliosis. Acta Neurol Scand 1995;91:353-57.
9. Adams WV, Rose CD, Eppes SC, Klein JD. Cognitive effects of Lyme disease in children. Pediatrics 1994;94:185-89.
10. Sangha O, Phillips CB, Fleischmann KE et al. Lack of cardiac manifestations among patients with previously treated Lyme disease. Ann Intern Med 1998;128:346-53.
11. Shotland LI, Mastrioanni MA, Choo DL et al. Audiologic manifestations of patients with post-treatment Lyme disease syndrome. Ear Hear 2003;24:508-17.
12. Wharton M, Chorba TL, Vogt RL, Morse DL, Buehler JW. Centers for disease control and prevention. Case definitions for public health surveillance. MMWR Morb Mortal Wkly Rep 1990;39:19-21.
13. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta-blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71.
14. Wormser GP, Nadelman RB, Dattwyler RJ et al. Practice guidelines for the treatment of Lyme disease. Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2000;31(Suppl 1):S1-S14.
15. Krupp LB, Masur D, Schwartz J et al. Cognitive functioning in late Lyme borreliosis. Arch Neurol 1991;48:1125-9.
16. Gaudino EA, Coyle PK, Krupp LB. Post-Lyme syndrome and chronic fatigue syndrome. Neuropsychiatric similarities and differences. Arch Neurol 1997;54:1372-76.
17. Kaplan RF, Jones-Woodward L, Workman K, Steere AC, Logigian EL, Meadows ME. Neuropsychological deficits in Lyme disease patients with and without other evidence of central nervous system pathology. Appl Neuropsychol 1999;6:3-11.
18. Kaplan RF, Meadows ME, Vincent LC, Logigian EL, Steere AC. Memory impairment and depression in patients with Lyme encephalopathy: comparison with fibromyalgia and nonpsychotically depressed patients. Neurology 1992;42:1263-67.
19. Bujak DI, Weinstein A, Dornbush RL. Clinical and neurocognitive features of the post Lyme syndrome. J Rheumatol 1996;23:1392-97.
20. Tager FA, Fallon BA, Keilp J, Rissenberg M, Jones CR, Liebowitz MR. A controlled study of cognitive deficits in children with chronic Lyme disease. J Neuropsychiatry Clin Neurosci 2001;13:500-7.
21. Fallon BA, Keilp J, Prohovnik I, Heertum RV, Mann JJ. Regional blood flow and cognitive deficits in chronic Lyme disease. J Neuropsychiatry Clin Neurosci 2003;15:326-32.
22. Elkins LE, Pollina DA, Scheffer SR, Krupp LB. Psychological states and neuropsychological performances in chronic Lyme disease. Appl Neuropsychol 1999;6:19-26.
23. Weinstein A, Klempner MS. Treatment of patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001; 345:1424-25.
24. Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest 2004;113:1093-101.
25. Klempner MS, Linden TH, Evans J et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001;345:85-92.
26. Kaplan RF, Trevino RP, Johnson GM et al. Cognitive function in post-treatment Lyme disease. Do additional antibiotics help? Neurology 2003;60:1916-22.
27. Krupp LB, Hyman LG, Grimson R et al. Study and treatment of post Lyme disease (STOP-LD): A randomized double masked clinical trial. Neurology 2003;60:1923-30.
28. German National Reference Centre for Borreliosis. Lyme Borreliosis [in German]. Available at: http://pollux.mpk.med.uni-muenchen.de/alpha1/ nrz-borrelia/lb (Accessed November 25, 2004).
29. O'Connell S, Granstroem M, Gray JS, Stanek G. Epidemiology of European Lyme borreliosis. Zentr bl Bakteriol 1998;287:229-40.
30. Orloski KA, Hayes EB, Campbell GL, Dennis DT. Surveillance for Lyme disease - United States 1992-1998. Centers for Disease Control and Prevention Surveillance Summaries. MMWR Morb Mortal Wkly Rep 2000;49:1-11.
31. Centers for Disease Control and Prevention. Lyme disease - United States, 2001-2002. MMWR Morb Mortal Wkly Rep 2004; 53:365-69.
32. Meek JI, Roberts CL, Smith EV Jr, Cartter ML. Underreporting of Lyme disease by Connecticut physicians, 1992. J Public Health Manag Pract 1996;2:61-65.
33. Coyle BS, Strickland GT, Liang YY, Pena C, McCarter R, Israel E. Public impact of Lyme disease in Maryland. J Infect Dis 1996;173: 1260-62.